OFID is seeking research on infectious diseases in rural areas in the U.S., incl. fungal, bacterial, viral and parasitic infections, investments in ID workforce development and strategies for addressing vaccine hesitancy. Submit a proposal by Sept. 13: https://bit.ly/4xjOhzl

Clinical features and outcomes of pediatric Lyme arthritis in Europe: a large Swiss cohort study ✅ Just Accepted 🔗 https://bit.ly/4fPwAR5

Parallel Declines in HPV6/11-Related Disease Incidences: A National Study of Anogenital Warts and Recurrent Respiratory Papillomatosis in Norway ✅ Just Accepted 🔗 https://bit.ly/3Sdrvu5

Serious fungal diseases: Assessing the impact of training clinicians and laboratory scientists in Nigeria ✅ Just Accepted 🔗 https://bit.ly/4pQA8r3

Non-tuberculous mycobacterial infections at a National Cancer Institute-Designated Comprehensive Cancer Center in Florida ✅ Just Accepted 🔗 https://bit.ly/4wL0FbN

Contemporary Single and Multi-tablet HIV Treatment Regimens Are Associated with Similar Levels of Viral Suppression ✅ Just Accepted ⭐ Editor's Choice 🔗 https://bit.ly/4yXlKS0

VOGUE: Non-Inferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment ✅ Just Accepted https://bit.ly/4pUJ7aL

VOGUE: Non-Inferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment

In the first randomized, head-to-head trial in adults initiating antiretroviral therapy, dolutegravir/lamivudine demonstrated non-inferior efficacy to bict

bit.ly

Rapid Virologic Suppression With DTG/3TC Facilitates Early Switch to CAB+RPV LA for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study ✅ Just Accepted https://bit.ly/4fwy6sy

Rapid Virologic Suppression With DTG/3TC Facilitates Early Switch to CAB+RPV LA for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study

AbstractBackground. Long-acting cabotegravir+rilpivirine (CAB+RPV LA) and dolutegravir+lamivudine (DTG/3TC) are HIV-1 antiretroviral therapy regimens with

bit.ly

Measles in Ugandan Children Under 18 Months of Age: A retrospective study of case-based surveillance, 2018–2024 ✅ Just Accepted 🔗 https://bit.ly/454HopB

Bacterial infection in Ebola virus disease, Marburg virus disease, Crimean–Congo hemorrhagic fever, and Lassa fever ✅ Just Accepted 🔗 https://bit.ly/4yQnNaf

Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: modeling the potential impact on vertical transmission ✅ Just Accepted 🔗 https://bit.ly/3U4S0lV

OFID has launched a new special section, Notes from the Epidemic Frontlines, offering a rapid platform for ID professionals on the frontlines of outbreaks and epidemics to share timely observations, experiences and critical insights. Browse the articles: https://bit.ly/4htcPRE

Comparative Effectiveness of Teicoplanin Versus Standard of Care Antibiotics for the Treatment of Gram-Positive Bacteremia: A Seven-Year Retrospective Analysis ✅ Just Accepted 🔗 https://bit.ly/4fs6CUS

Prevalence, serotype distribution and risk factors associated with Streptococcus pneumoniae carriage in older adults in Denmark, 2019-2022 ✅ Just Accepted 🔗 https://bit.ly/4hnCEmv

Interobserver agreement for classifying infections in emergency department patients using modified Centers for Disease Control and Prevention criteria ✅ Just Accepted 🔗 https://bit.ly/4yREEd0

Neighborhood Deprivation, Antibiotic Prescribing Concordance, and 30-Day Outcomes After Emergency Department Encounters in Older Adults ✅ Just Accepted 🔗 https://bit.ly/3U0upTn

Harmonization of Real-World Data for Vaccine-Preventable Infectious Diseases: Integration of SARS-CoV-2 Diagnostic and Serologic Data from Multiple Sources ✅ Just Accepted 🔗 https://bit.ly/4pHKIAp

Thiazolidinedione use and risk of bacterial enteric infection among adults with type 2 diabetes mellitus ✅ Just Accepted 🔗 https://bit.ly/4vPfM2v

Hepatitis C Treatment Outcomes Among Immigrants: A CANUHC Cohort Analysis ✅ Just Accepted 🔗 https://bit.ly/4pHm6Yv

Durability of RSV Antibodies After Vaccination in Immunosuppressed Persons ✅ Just Accepted 🔗 https://bit.ly/4bIDFBI

Point-of-Care Multiplex NAAT for Acute Pharyngitis in the Urgent Care: Detection Patterns, Associated Antimicrobial Prescribing, and Stakeholder Perceptions ✅ Just Accepted 🔗 https://bit.ly/3TVy4BS

Outpatient Management of Imported Non-Severe Falciparum Malaria in Adults in the United Kingdom: a Multi-Site Evaluation of Clinical Safety and Costing Analysis ✅ Just Accepted 🔗 https://bit.ly/3RzimM1

Emergence of Integrase Strand Transfer Inhibitor Resistance Following Treatment of Latent Tuberculosis Infection in a Patient With HIV ✅ Just Accepted 🔗 https://bit.ly/4fA6em6

Characteristics, treatment strategies, and long-term health outcomes of people with bedaquiline-resistant tuberculosis in Karakalpakstan, Uzbekistan – a retrospective cohort study ✅ Just Accepted 🔗 https://bit.ly/4vJLfDi

Local prevalence of ceftriaxone resistance informs optimal deployment of new gonorrhea treatments ✅ Just Accepted 🔗 https://bit.ly/4yHT0fS

Durability and Breadth of Neutralizing Antibodies Against SARS-CoV-2 Variants Following XBB.1.5 Vaccination in a Multiply Exposed Cohort ✅ Just Accepted 🔗 https://bit.ly/3RbMo8F

Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhea: nucleic acid amplification testing (NAAT) outcomes in a randomized, multicenter phase 3 trial (EAGLE-1) ✅ Just Accepted 🔗 https://bit.ly/4gRU4Y6

OFID has launched a new special section, Notes from the Epidemic Frontlines, offering a rapid platform for ID professionals on the frontlines of outbreaks and epidemics to share timely observations, experiences and critical insights. Browse the articles: https://bit.ly/4htcPRE

A dynamic prediction study of persistent nine-valent human papillomavirus infection among HIV-negative men who have sex with men in Urumqi, China: a longitudinal and time-to-event-based joint model ✅ Just Accepted 🔗 https://bit.ly/4bnU5Q3

Pediatric Hemolytic Uremic Syndrome in North-Eastern Germany during the STEC O45:H2 Outbreak in 2025: Clinical Features and Short-Term Outcomes ✅ Just Accepted 🔗 https://bit.ly/3Rhs0Tz